# Fluconazole Versus Micafungin in Neonates With Candidiasis

> **NCT02145832** · PHASE2,PHASE3 · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 100 (estimated)

## Conditions studied

- Candidiasis

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT02145832
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145832, "Fluconazole Versus Micafungin in Neonates With Candidiasis". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT02145832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*